Abstract
The main milestones in the exploration and validation of cancer breathprint for the advancement of personalised diagnosis and medicine are summarised here, with a special attention to the appraisal and translation of the accumulating knowledge from the laboratory to the Point-of-Care phase. An outlook into the opportunities of the use of breathprints and their wider availability for healthcare is offered.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Phillips M. Breath tests in medicine. Sci Am. 192;267:74–9.
Hakim M, Broza YY, Barash O, Peled N, Phillips M, Amann A, et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev. 2012;112:5949–66.
Broza YY, Vishinkin R, Barash O, Nakhleh MK, Haick H. Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation. Chem Soc Rev. 2018;47:4781–859.
Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer. 2010;103:542–51.
Hakim M, Billan S, Tisch U, Peng G, Dvorkind I, Marom O, et al. Diagnosis of head-and-neck cancer from exhaled breath. Br J Cancer. 2011;104:1649–55.
Nakhleh MK, Amal H, Jeries R, Broza YY, Aboud M, Gharra A, et al. Diagnosis and classification of 17 diseases from 1404 subjects via pattern analysis of exhaled molecules. ACS Nano. 2017;11:112–25.
Amal H, Leja M, Funka K, Skapars R, Sivins A, Ancans G, et al. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut. 2016;65:400–7.
Xu ZQ, Ionsecu R, Broza Y, Tisch U, Ding L, Liu H, et al. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer. 2013;108:941–50.
Shlomi D, Abud M, Liran O, Bar J, Gai-Mor N, Ilouze M, et al. Detection of lung cancer and EGFR mutation by electronic nose system. J Thorac Oncol. 2017;12:1544–51.
Barash O, Zhang W, Halpern JM, Hua QL, Pan YP, Kayal H, et al. Differentiation between genetic mutations of breast cancer by breath volatolomics. Oncotarget. 2015;6:44864–76.
Acknowledgements
The author thanks all researchers and students in the LNBD group as well as collaborators through the years for their thorough, excellent and fruitful contributions and partnership.
Funding
None.
Author information
Authors and Affiliations
Contributions
H.H. wrote and proofed this comment.
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Ethics approval and consent to participate
Not applicable.
Consent to publish
Not applicable.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Haick, H. The diagnostic breathprint of cancer; the past and the future. Br J Cancer 128, 448–450 (2023). https://doi.org/10.1038/s41416-022-01987-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-022-01987-0